Efficacy of single-dose and double-dose ivermectin early treatment in preventing progression to hospitalization in mild COVID-19: A multi-arm, parallel-group randomized, double-blind, placebo-controlled trial.
Alireza MirahmadizadehAli SematiAlireza HeiranMostafa EbrahimiAbdolrasool HemmatiMohammadreza KarimiSouzan BasirMarjan ZareAntonio Charlys da CostaMohammad ZeinaliMaryam SargolzaeeOwrang EilamiPublished in: Respirology (Carlton, Vic.) (2022)
Single-dose and double-dose ivermectin early treatment were not superior to the placebo in preventing progression to hospitalization and improving clinical course in mild COVID-19.